Teva Pharmaceutical Industries (TASE:TEVA) Q3 2026 Earnings Call
Teva Pharmaceutical Industries (TASE:TEVA) reports Q3 2026 results on this call. Live coverage runs here, and the full replay with transcript and chapters lands on this page after the call.
- Company
- Teva Pharmaceutical Industries Limited (TASE:TEVA)
- Period
- Q3 2026 earnings call
- Date
- Tue, Nov 3, 2026, 8:00 AM ET
On 6ix: 6ix.com/event/teva-pharmaceutical-industries-limited-teva-q3-2026-earnings-call
Latest news releases
- TASE:TEVA — Samsung Bioepis and Teva Expand Strategic Partnership to Advance Up to Six Potential Biosimilar Candidates · Thu, Oct 1, 2026
- TASE:TEVA — Teva Continues Biosimilar Momentum with U.S. FDA Approval of DEGEVMA™ (denosumab-adet), a Biosimilar to Xgeva® (denosumab) · Mon, Sep 28, 2026